1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > U.S. Multiple Sclerosis Industry 2015 Market Research Report

U.S. Multiple Sclerosis Industry 2015 Market Research Report

  • August 2015
  • -
  • QY Research Group
  • -
  • 271 pages

Summary


The U.S. Multiple Sclerosis Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Multiple Sclerosis industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Multiple Sclerosis market analysis is provided for the U.S. markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on U.S. major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Multiple Sclerosis industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 287 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

U.S. Multiple Sclerosis Industry 2015 Market Research Report
Table of Contents

Chapter One Industry Overview
1.1 Definition and Specifications of Multiple Sclerosis
1.2 Classification of Multiple Sclerosis
1.3 Applications of Multiple Sclerosis
1.4 Industry Chain Structure of Multiple Sclerosis
1.5 Industry Overview of Multiple Sclerosis
1.6 Industry Policy Analysis of Multiple Sclerosis
1.7 Industry News Analysis of Multiple Sclerosis

Chapter Two Manufacturing Cost Structure Analysis of Multiple Sclerosis
2.1 Bill of Materials (BOM) of Multiple Sclerosis
2.2 BOM Price Analysis of Multiple Sclerosis
2.3 Labor Cost Analysis of Multiple Sclerosis
2.4 Depreciation Cost Analysis of Multiple Sclerosis
2.5 Manufacturing Cost Structure Analysis of Multiple Sclerosis
2.6 Manufacturing Process Analysis of Multiple Sclerosis

Chapter Three Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of U.S. Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of U.S. Key Multiple Sclerosis Manufacturers in 2014
3.3 RandD Status and Technology Source of U.S. Multiple Sclerosis Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of U.S. Multiple Sclerosis Key Manufacturers in 2014

Chapter Four Production Analysis of Multiple Sclerosis by Regions, Technology, and Applications
4.1 U.S. Production of Multiple Sclerosis by Regions (Key Provinces) 2010-2015
4.2 U.S. Production of Multiple Sclerosis by Product Types 2010-2015
4.3 U.S. Sales of Multiple Sclerosis by Applications 2010-2015
4.4 Price Analysis of U.S. Multiple Sclerosis Key Manufacturers in 2015
4.5 U.S. Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Multiple Sclerosis 2010-2015

Chapter Five Sales and Revenue Analysis of Multiple Sclerosis by Regions
5.1 U.S. Sales of Multiple Sclerosis by Regions 2010-2015
5.2 U.S. Revenue of Multiple Sclerosis by Regions 2010-2015
5.3 U.S. Price Analysis of Multiple Sclerosis Sales by Regions 2010-2015
5.4 U.S. Price, Cost and Gross of Multiple Sclerosis 2010-2015

Chapter Six Analysis of Multiple Sclerosis Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity Production Sales Revenue of Multiple Sclerosis 2010-2015
6.2 Production Sales Market Share Analysis of Multiple Sclerosis 2014-2015
6.3 Import, Export and Consumption of Multiple Sclerosis 2010-2015
6.4 Supply, Consumption and Shortage of Multiple Sclerosis 2010-2015
6.5 Import, Export and Consumption of Multiple Sclerosis 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Multiple Sclerosis 2010-2015

Chapter Seven Analysis of Multiple Sclerosis Industry Key Manufacturers
7.1 Bayer
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Bayer SWOT Analysis

7.2 Biogen
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Biogen SWOT Analysis

7.3 Merck Serono
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Merck Serono SWOT Analysis

7.4 Novartis
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Novartis SWOT Analysis

7.5 Teva Pharmaceutical Industries
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Teva Pharmaceutical Industries SWOT Analysis

7.6 AB Science
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 AB Science SWOT Analysis

7.7 Abbvie
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Abbvie SWOT Analysis

7.8 Acorda Therapeutics
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Acorda Therapeutics SWOT Analysis

7.9 Active Biotech
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Active Biotech SWOT Analysis

7.10 Artielle
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Artielle SWOT Analysis

7.11 Astellas
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Astellas SWOT Analysis

7.12 AstraZeneca
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 AstraZeneca SWOT Analysis

7.13 Canbex
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Canbex SWOT Analysis

7.14 F. Hoffmann-La Roche
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 F. Hoffmann-La Roche SWOT Analysis

7.15 GeNeuro
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 GeNeuro SWOT Analysis

7.16 GlaxoSmithKline
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 GlaxoSmithKline SWOT Analysis

7.17 Glenmark
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Glenmark SWOT Analysis

7.18 InnoBioscience Pharmaceuticals
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 InnoBioscience Pharmaceuticals SWOT Analysis

7.19 Ipsen
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 Ipsen SWOT Analysis

7.20 Mapi-Pharma
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 Mapi-Pharma SWOT Analysis

7.21 medDay Pharmaceuticals
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 medDay Pharmaceuticals SWOT Analysis

7.22 MediciNova
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 MediciNova SWOT Analysis

7.23 Mitsubishi Tanabe
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.23.4 Mitsubishi Tanabe SWOT Analysis

7.24 Opexa Therapeutics
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.24.4 Opexa Therapeutics SWOT Analysis

7.25 Osmotica
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.25.4 Osmotica SWOT Analysis

7.26 Pfizer
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.26.4 Pfizer SWOT Analysis

7.27 Receptos
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.27.4 Receptos SWOT Analysis

7.28 RedHill Biopharma
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.28.4 RedHill Biopharma SWOT Analysis

7.29 Sanofi
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.29.4 Sanofi SWOT Analysis

7.30 Trophos
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.30.4 Trophos SWOT Analysis

7.31 XenoPort
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.31.4 XenoPort SWOT Analysis

Chapter Eight Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Multiple Sclerosis Product Types
8.5 Market Share Analysis of Different Multiple Sclerosis Price Levels
8.6 Gross Margin Analysis of Different Multiple Sclerosis Applications

Chapter Nine Marketing Trader or Distributor Analysis of Multiple Sclerosis
9.1 Marketing Channels Status of Multiple Sclerosis
9.2 Traders or Distributors of Multiple Sclerosis with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Multiple Sclerosis
9.4 U.S. Import, Export and Trade Analysis of Multiple Sclerosis

Chapter Ten Development Trend of Multiple Sclerosis Industry 2015-2020
10.1 Capacity and Production Overview of Multiple Sclerosis 2015-2020
10.2 Production Market Share by Product Types of Multiple Sclerosis 2015-2020
10.3 Sales and Sales Revenue Overview of Multiple Sclerosis 2015-2020
10.4 U.S. Sales of Multiple Sclerosis by Applications 2015-2020
10.5 Import, Export and Consumption of Multiple Sclerosis 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Multiple Sclerosis 2015-2020

Chapter Eleven Industry Chain Suppliers of Multiple Sclerosis with Contact Information
11.1 Major Raw Materials Suppliers of Multiple Sclerosis with Contact Information
11.2 Manufacturing Equipment Suppliers of Multiple Sclerosis with Contact Information
11.3 Major Players of Multiple Sclerosis with Contact Information
11.4 Key Consumers of Multiple Sclerosis with Contact Information
11.5 Supply Chain Relationship Analysis of Multiple Sclerosis

Chapter Twelve New Project Investment Feasibility Analysis of Multiple Sclerosis
12.1 New Project SWOT Analysis of Multiple Sclerosis
12.2 New Project Investment Feasibility Analysis of Multiple Sclerosis

Chapter Thirteen Conclusion of the U.S. Multiple Sclerosis Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Multiple Sclerosis
Table Product Specifications of Multiple Sclerosis
Table Classification of Multiple Sclerosis
Figure U.S. Sales Market Share of Multiple Sclerosis by Product Types in 2014
Table Applications of Multiple Sclerosis
Figure U.S. Sales Market Share of Multiple Sclerosis by Applications in 2014
Figure Industry Chain Structure of Multiple Sclerosis
Table U.S. Industry Overview of Multiple Sclerosis
Table Industry Policy of Multiple Sclerosis
Table Industry News List of Multiple Sclerosis
Table Bill of Materials (BOM) of Multiple Sclerosis
Table Bill of Materials (BOM) Price of Multiple Sclerosis
Table Labor Cost of Multiple Sclerosis
Table Depreciation Cost of Multiple Sclerosis
Table Manufacturing Cost Structure Analysis of Multiple Sclerosis in 2014
Figure Manufacturing Process Analysis of Multiple Sclerosis
Table Capacity (K Person-portion) and Commercial Production Date of U.S. Multiple Sclerosis Key Manufacturers in 2014
Table Manufacturing Plants Distribution of U.S. Key Multiple Sclerosis Manufacturers in 2014
Table RandD Status and Technology Source of U.S. Multiple Sclerosis Key Manufacturers in 2014
Table Raw Materials Sources Analysis of U.S. and U.S. Multiple Sclerosis Key Manufacturers in 2014
Table U.S. Production of Multiple Sclerosis by Regions 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Multiple Sclerosis by Regions 2010-2015 (%)
Figure U.S. Production Market Share of Multiple Sclerosis by Regions in 2014
Figure U.S. Production Market Share of Multiple Sclerosis by Regions in 2015
Table U.S. Production of Multiple Sclerosis by Product Types in 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Multiple Sclerosis by Product Types in 2010-2015 (%)
Figure U.S. Production Market Share of Multiple Sclerosis by Technology in 2014
Figure U.S. Production Market Share of Multiple Sclerosis by Technology in 2015
Figure U.S. Sales of Multiple Sclerosis by Applications 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Multiple Sclerosis by Applications 2010-2015 (%)
Figure U.S. Production Market Share of Multiple Sclerosis by Applications in 2014
Figure U.S. Production Market Share of Multiple Sclerosis by Applications in 2015
Table Price Comparison of U.S. Multiple Sclerosis Key Manufacturers in 2015 (USD/Person-portion)
Table U.S. Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Multiple Sclerosis 2010-2015
Table U.S. Sales of Multiple Sclerosis by Regions 2010-2015 (K Person-portion)
Table U.S. Sales Market Share of Multiple Sclerosis by Regions 2010-2015 (%)
Figure U.S. Sales of Multiple Sclerosis by Regions in 2014 (K Person-portion)
Figure U.S. Sales of Multiple Sclerosis by Regions in 2015 (K Person-portion)
Table U.S. Revenue of Multiple Sclerosis by Regions 2010-2015 (M USD)
Table U.S. Revenue of Multiple Sclerosis by Regions 2010-2015 (%)
Figure U.S. Revenue of Multiple Sclerosis by Regions in 2014 (%)
Figure U.S. Revenue of Multiple Sclerosis by Regions in 2015 (%)
Table Sales Price of Multiple Sclerosis by Regions 2010-2015 (USD/Person-portion)
Table U.S. Price Analysis of Multiple Sclerosis 2010-2015 (USD/Person-portion)
Table U.S. Cost Analysis of Multiple Sclerosis 2010-2015 (USD/Person-portion)
Table U.S. Gross Analysis of Multiple Sclerosis 2010-2015
Table U.S. and Major Manufacturers Capacity of Multiple Sclerosis 2010-2015 (K Person-portion)
Table U.S. Capacity Market Share of Major Multiple Sclerosis Manufacturers 2010-2015 (%)
Table U.S. and Major Manufacturers Production of Multiple Sclerosis 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Major Multiple Sclerosis Manufacturers 2010-2015 (%)
Table U.S. and Major Manufacturers Sales of Multiple Sclerosis 2010-2015 (K Person-portion)
Table U.S. Sales Market Share of Major Multiple Sclerosis Manufacturers 2010-2015 (%)
Table U.S. and Major Manufacturers Sales Revenue of Multiple Sclerosis 2010-2015 (M USD)
Table U.S. Sales Revenue Market Share of Major Multiple Sclerosis Manufacturers 2010-2015 (%)
Figure U.S. Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Multiple Sclerosis 2010-2015
Figure U.S. Capacity Utilization Rate of Multiple Sclerosis 2010-2015
Figure U.S. Sales Revenue (M USD) and Growth Rate of Multiple Sclerosis 2010-2015
Figure U.S. Production Market Share of Major Multiple Sclerosis Manufacturers in 2014
Figure U.S. Production Market Share of Major Multiple Sclerosis Manufacturers in 2015
Figure U.S. Sales Market Share of Major Multiple Sclerosis Manufacturers in 2014
Figure U.S. Sales Market Share of Major Multiple Sclerosis Manufacturers in 2015
Table U.S. Import, Export and Consumption of Multiple Sclerosis 2010-2015 (K Person-portion)
Table U.S. and Major Manufacturers Local Sales Export Import of Multiple Sclerosis 2010-2015 (K Person-portion)
Table U.S. Supply, Consumption and Shortage of Multiple Sclerosis 2010-2015 (K Person-portion)
Table U.S. Import, Export and Consumption of Multiple Sclerosis 2010-2015 (K Person-portion)
Table Price of U.S. Multiple Sclerosis Major Manufacturers 2010-2015 (USD/Person-portion)
Table Gross Margin of U.S. Multiple Sclerosis Major Manufacturers 2010-2015
Table U.S. and Major Manufacturers Revenue of Multiple Sclerosis 2010-2015 (M USD)
Table U.S. Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Multiple Sclerosis 2010-2015
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Bayer
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Bayer 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Bayer 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Bayer 2010-2015
Table Bayer Multiple Sclerosis SWOT Analysis
Table Biogen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Biogen
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Biogen 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Biogen 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Biogen 2010-2015
Table Biogen Multiple Sclerosis SWOT Analysis
Table Merck Serono Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Merck Serono
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Merck Serono 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Merck Serono 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Merck Serono 2010-2015
Table Merck Serono Multiple Sclerosis SWOT Analysis
Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Novartis
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Novartis 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Novartis 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Novartis 2010-2015
Table Novartis Multiple Sclerosis SWOT Analysis
Table Teva Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Teva Pharmaceutical Industries
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Teva Pharmaceutical Industries 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Teva Pharmaceutical Industries 2010-2015
Table Teva Pharmaceutical Industries Multiple Sclerosis SWOT Analysis
Table AB Science Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of AB Science
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of AB Science 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of AB Science 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of AB Science 2010-2015
Table AB Science Multiple Sclerosis SWOT Analysis
Table Abbvie Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Abbvie
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Abbvie 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Abbvie 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Abbvie 2010-2015
Table Abbvie Multiple Sclerosis SWOT Analysis
Table Acorda Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Acorda Therapeutics
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Acorda Therapeutics 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Acorda Therapeutics 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Acorda Therapeutics 2010-2015
Table Acorda Therapeutics Multiple Sclerosis SWOT Analysis
Table Active Biotech Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Active Biotech
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Active Biotech 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Active Biotech 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Active Biotech 2010-2015
Table Active Biotech Multiple Sclerosis SWOT Analysis
Table Artielle Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Artielle
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Artielle 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Artielle 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Artielle 2010-2015
Table Artielle Multiple Sclerosis SWOT Analysis
Table Astellas Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Astellas
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Astellas 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Astellas 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Astellas 2010-2015
Table Astellas Multiple Sclerosis SWOT Analysis
Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of AstraZeneca
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of AstraZeneca 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of AstraZeneca 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of AstraZeneca 2010-2015
Table AstraZeneca Multiple Sclerosis SWOT Analysis
Table Canbex Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Canbex
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Canbex 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Canbex 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Canbex 2010-2015
Table Canbex Multiple Sclerosis SWOT Analysis
Table F. Hoffmann-La Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of F. Hoffmann-La Roche
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of F. Hoffmann-La Roche 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of F. Hoffmann-La Roche 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of F. Hoffmann-La Roche 2010-2015
Table F. Hoffmann-La Roche Multiple Sclerosis SWOT Analysis
Table GeNeuro Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of GeNeuro
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of GeNeuro 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of GeNeuro 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of GeNeuro 2010-2015
Table GeNeuro Multiple Sclerosis SWOT Analysis
Table GlaxoSmithKline Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of GlaxoSmithKline
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of GlaxoSmithKline 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of GlaxoSmithKline 2010-2015
Table GlaxoSmithKline Multiple Sclerosis SWOT Analysis
Table Glenmark Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Glenmark
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Glenmark 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Glenmark 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Glenmark 2010-2015
Table Glenmark Multiple Sclerosis SWOT Analysis
Table InnoBioscience Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of InnoBioscience Pharmaceuticals
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of InnoBioscience Pharmaceuticals 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of InnoBioscience Pharmaceuticals 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of InnoBioscience Pharmaceuticals 2010-2015
Table InnoBioscience Pharmaceuticals Multiple Sclerosis SWOT Analysis
Table Ipsen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Ipsen
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Ipsen 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Ipsen 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Ipsen 2010-2015
Table Ipsen Multiple Sclerosis SWOT Analysis
Table Mapi-Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Mapi-Pharma
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Mapi-Pharma 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Mapi-Pharma 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Mapi-Pharma 2010-2015
Table Mapi-Pharma Multiple Sclerosis SWOT Analysis
Table medDay Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of medDay Pharmaceuticals
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of medDay Pharmaceuticals 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of medDay Pharmaceuticals 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of medDay Pharmaceuticals 2010-2015
Table medDay Pharmaceuticals Multiple Sclerosis SWOT Analysis
Table MediciNova Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of MediciNova
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of MediciNova 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of MediciNova 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of MediciNova 2010-2015
Table MediciNova Multiple Sclerosis SWOT Analysis
Table Mitsubishi Tanabe Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Mitsubishi Tanabe
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Mitsubishi Tanabe 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Mitsubishi Tanabe 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Mitsubishi Tanabe 2010-2015
Table Mitsubishi Tanabe Multiple Sclerosis SWOT Analysis
Table Opexa Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Opexa Therapeutics
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Opexa Therapeutics 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Opexa Therapeutics 2010-2015
Figure Multiple Sclerosis Production (K Person-portion) and U.S. Market Share of Opexa Therapeutics 2010-2015
Table Opexa Therapeutics Multiple Sclerosis SWOT Analysis
Table Osmotica Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Multiple Sclerosis Picture and Specifications of Osmotica
Table Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Osmotica 2010-2015
Figure Multiple Sclerosis Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Osmotica 2010-2015
Figure Multiple Sclero

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Epilepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...

Narcolepsy-Market Insights, Epidemiology and Market Forecast-2023

Narcolepsy-Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Narcolepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...

Myasthenia Gravis-Market Insights, Epidemiology and Market Forecast-2023

Myasthenia Gravis-Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Myasthenia Gravis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


Download Unlimited Documents from Trusted Public Sources

Neurological Disorder Statistics in China

  • November 2016
    32 pages
  • Neurological Di...  

    Stroke  

    Neurology  

  • China  

View report >

Global Mental Health Statistics - Forecast

  • November 2016
    12 pages
  • Mental Health  

  • World  

    Greece  

View report >

Depression Statistics in Canada

  • October 2016
    32 pages
  • Depression  

    Mental Health  

    Neurological Di...  

  • Canada  

    North America  

View report >

Related Market Segments :

Neurological Disorder

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.